Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-10 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-09 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-09 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-07 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-07 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |